医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Custom PCR Master Mixes Ship in 10 Days with New Promega cGMP PCR Kit for Rapid Assay Development

2016年11月03日 PM10:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

Now available, the Promega PCR Optimization Kit allows customers to rapidly define their own unique PCR master mix manufactured under cGMP for research or clinical use. The user’s defined optimal solution may then be ordered from Promega at any time with a unique part number as a custom cGMP master mix for shipment within ten business days.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161103005377/en/

The New Promega cGMP PCR Optimization Kit allows customers to rapidly define their own PCR master mi ...

The New Promega cGMP PCR Optimization Kit allows customers to rapidly define their own PCR master mix, which may then be shipped within ten business days. (Photo: Business Wire)

The PCR Optimization Kit includes magnesium chloride, GoTaq® MDx Hot Start Polymerase, and eight PCR buffers with an array of performance characteristics all manufactured under cGMP. The accompanying user guide provides instruction to quickly isolate the ideal configurations for a variety of PCR applications.

Doug Storts, Ph.D., Head of Research at Promega, calls the system a game changer for assay developers who will no longer be forced to settle for one-size-fits-all catalog master mixes. “In the early days of PCR, labs developed significant expertise in modulating and optimizing PCR incubation times and temperatures, enzyme choices, and salt concentrations,” says Storts. “The Promega PCR Optimization Kit returns this level of expertise to every lab by offering the component choices along with a map to the best possible solution.”

Early access users have identified their ideal PCR assays in as little as one month from receipt of the PCR Optimization Kit. And because the components of the PCR Optimization Kits are available in product inventory, Promega can supply additional components as needed for special purposes, such as identifying a master mix that will work across multiple applications.

This is the approach taken by the Children’s Hospital of Colorado, where Qi Wei, Ph.D., Scientific Director of the Molecular Diagnostics Lab, uses the kit to optimize multiple qPCR viral quant tests. He observed, “The Promega kit simplifies the complexity of PCR formulation options without compromising flexible and fast performance optimization.”

Learn more at www.Promega/MyMasterMix.com.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 3,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161103005377/en/

CONTACT

Promega Corporation
Penny Patterson
Sr. Director,
Communications
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続